Communicating scientific research to the wider public is an important part of fostering awareness of emerging healthcare innovations and their potential societal impact. Science communication initiatives help bridge the gap between research and society, making complex scientific topics more accessible to diverse audiences.
Fetalix was featured on 90 Segundos de Ciência, a Portuguese science communication programme that showcases research and innovation developed in Portugal through short interviews with researchers. Broadcasted on national radio and available as a podcast, the programme highlights scientific projects across a wide range of disciplines, bringing cutting-edge research closer to the general public.
During the feature, Fetalix co-founder and CEO Joana Caldeira introduced the company's vision and discussed the development of its regenerative biomaterial for the treatment of intervertebral disc degeneration. The interview also highlighted the importance of translating scientific research into innovative healthcare solutions with the potential to benefit both human and veterinary medicine.
By participating in initiatives such as 90 Segundos de Ciência, Fetalix contributes to promoting public engagement with science while increasing the visibility of regenerative medicine research and its potential to address significant unmet clinical needs.
May 11, 2022
